Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > Podcast on Viemed:
View:
Post by LongTerm3 on Apr 19, 2021 3:56pm

Podcast on Viemed:

https://seekingalpha.com/article/4419854-cove-street-capital-discusses-viemed?mail_subject=vmd-cove-street-capital-discusses-viemed&utm_campaign=rta-stock-article&utm_content=link-2&utm_medium=email&utm_source=seeking_alpha
Comment by Tropicalsun on Apr 19, 2021 6:13pm
LongTerm3 really great find, thanks for sharing. If you are a current shareholder, or potential investor this is a must watch video podcast. It is an hour long, but so full of valuable and head scratching information. As mentioned, the runway is massive for this little company. The repeat message that these guys kept hammering on was the mind boggling fact that Viemed has grown year over year at ...more  
Comment by donmayne on Apr 20, 2021 8:19am
It really is an indepth interview.  Their valuation focus was on EBITA growth which took them to $US18 valuation in 2.5-3 years. This would make their one year target about 30% higher than today's value.  This is in line with the other analysts.  They also referenced that Viemed was relatively unknown and prided themselves on discovering it for their fund of undervalued small ...more  
Comment by ValueCat on Apr 22, 2021 2:45pm
What I didn't like was the moderator giving VMD credit for achieving 30-40% organic, non Covid growth.  That is an aspirational goal at this point.  Also no mention of the one-off nature of the Covid CF. Once we've finally cleaned out the Covid players in this stock, it should be OK.
Comment by JackLambert on Apr 22, 2021 4:29pm
I think the plan is the Covid cf gets quickly replaced with COPD4 cf.    the headcount suggests that's where they are positioning.   one thing I did like about Andrew leafs comments was the low capital nature of the model.   Just put a few respirators in the RTs cars and give them the list we got from local physicians.    Slick and quick.   I also like ...more  
Comment by JackLambert on Apr 22, 2021 4:39pm
And be where rural service is compensated at least as well as urban.   Sounds like the shape of things to come post pandemic.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities